Table 2.
Previous treatments for diabetic retinopathy
| Previous treatments for diabetic retinopathy | Yes | Number of indicated treatments
|
No | |||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | Other* | |||
| Focal/grid | 35 | 11 | 17 | 5 | 1 | 0 | 6 (1) | 18 |
| PRP | 16 | 8 | 6 | 2 | 0 | 0 | 0 | 37 |
| Bevacizumab | 17 | 6 | 4 | 1 | 3 | 0 | 8 (1), 12 (1), 19 (1) | 36 |
| Ranibizumab | 3 | 2 | 0 | 0 | 0 | 0 | 10 (1) | 50 |
| Triamcinolone | 18 | 10 | 6 | 2 | 0 | 0 | 0 | 35 |
Notes:
*
These data are formatted as number of treatments (number of patients receiving that number of treatments).
Abbreviations: Focal, focal laser photocoagulation; grid, grid laser photocoagulation; bevacizumab, intravitreal bevacizumab; ranibizumab, intravitreal ranibizumab; triamcinolone, intravitreal triamcinolone; PRP, panretinal photocoagulation.